No evidence that CAR T cell therapy causes secondary cancers, large study shows
Within a large group of more than 700 patients treated with CAR T cell therapy, researchers found no evidence that the ...
Pharm Exec42m
FDA Grants Fast Track Designation to Adicet Bio’s CAR T-cell Therapy for Systemic Lupus Erythematosus
The FDA has granted Fast Track Designation to Adicet Bio’s ADI-001, an allogeneic gamma delta CAR T-cell therapy, for ...
Upstate cancer survivor celebrates recovery with innovative CAR T-cell treatment
On this World Cancer Day, Chris Vogelsang, a cancer survivor from upstate New York, is celebrating his recovery thanks to a ...
News Medical on MSN1d
The CAR T Veteran: A Journey of Resilience, Remission, and Advocacy
Laurie Adami's experience with CAR T-cell therapy highlights its potential in treating Non-Hodgkin Lymphoma, emphasizing the ...
FierceBiotech6d
Cargo offloads CAR-T along with half of its workforce in wake of low efficacy, toxic side effects
The drug in question, called firicabtagene autoleucel or firi-cel, is an autologous CD22 CAR-T cell therapy that had been ...
STAT4d
CAR-T cells can arm other immune cells with engineered proteins to fight cancer, study says
Researchers found that bioengineered CAR-T cells when mixed with other immune cells can "donate" proteins, suggesting ...
CAR-T cells can arm bystander T cells with CAR molecules in tumor microenvironment
Engineered immune cells called CAR-T cells are used in the treatment of cancer. Researchers from Uppsala University have now ...
GEN2d
Making Strides Toward Off-the-Shelf CAR T Cell Therapy for Cancer
A new advance may make it possible to use off-the-shelf CAR T cells provided by healthy donors. The new approach studied in mice equipped CAR T cells with the viral protein Nef.
The Daily Pennsylvanian13d
Penn Medicine leads cancer treatment breakthroughs in CAR T-cell therapy
Penn Medicine is one of the first institutions to develop FDA-approved CAR T-cell therapies. This therapy is currently ...
The Scientist2d
Inducible CAR T Cells Target Solid Tumors Better
Researchers at Cellectis leveraged gene editing to create a CAR T cell that acts in an IF/THEN system. Traditional methods to develop CAR T cells that use the patient’s cells introduce challenges ...
Dog With Cancer 'Almost Back to Normal' After Pioneering New Treatment
Innovative research for a dog cancer treatment from the University of Missouri College of Veterinary Medicine has shown early ...
technologynetworks1d
Study Finds No Evidence CAR T-Cell Therapy Causes Secondary Cancers
A study of 783 patients treated with CAR T cell therapy found no evidence that the therapy itself caused secondary cancers.